0001181431-11-026368.txt : 20110502
0001181431-11-026368.hdr.sgml : 20110502
20110502173135
ACCESSION NUMBER: 0001181431-11-026368
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110428
FILED AS OF DATE: 20110502
DATE AS OF CHANGE: 20110502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DePinho Ronald A
CENTRAL INDEX KEY: 0001486420
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34655
FILM NUMBER: 11802133
MAIL ADDRESS:
STREET 1: AVEO PHARMACEUTICALS, INC.
STREET 2: 75 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVEO PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001325879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 SIDNEY STREET
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6172995000
MAIL ADDRESS:
STREET 1: 75 SIDNEY STREET
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
rrd309893.xml
DEPIHNO FORM 4
X0303
4
2011-04-28
0
0001325879
AVEO PHARMACEUTICALS INC
AVEO
0001486420
DePinho Ronald A
C/O AVEO PHARMACEUTICALS, INC.
75 SIDNEY STREET
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2011-04-28
4
S
0
10000
14.6958
D
240012
D
Common Stock
2011-04-28
4
S
0
10000
15.5258
D
230012
D
Common Stock
2011-04-28
4
S
0
10000
14.6938
D
232512
I
by spouse
Common Stock
2011-04-28
4
S
0
10000
15.5279
D
222512
I
by spouse
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2011.
The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.50 to $14.88, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.50 to $15.59, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on March 8, 2011.
These shares are held by the reporting person's spouse. The reporting person disclaims all beneficial ownership over all such shares, except to the extent of his pecuniary interest therein.
/s/ Joseph D. Vittiglio, attorney-in-fact
2011-05-02